U.S. markets open in 15 minutes
  • S&P Futures

    3,674.50
    +13.50 (+0.37%)
     
  • Dow Futures

    29,348.00
    +145.00 (+0.50%)
     
  • Nasdaq Futures

    11,339.75
    +6.00 (+0.05%)
     
  • Russell 2000 Futures

    1,679.00
    +10.60 (+0.64%)
     
  • Crude Oil

    79.80
    +1.30 (+1.66%)
     
  • Gold

    1,644.60
    +8.40 (+0.51%)
     
  • Silver

    18.28
    -0.06 (-0.31%)
     
  • EUR/USD

    0.9585
    -0.0013 (-0.13%)
     
  • 10-Yr Bond

    3.8660
    -0.0980 (-2.47%)
     
  • Vix

    32.78
    +0.52 (+1.61%)
     
  • GBP/USD

    1.0636
    -0.0095 (-0.88%)
     
  • USD/JPY

    144.5790
    -0.2120 (-0.15%)
     
  • BTC-USD

    19,050.01
    -1,105.21 (-5.48%)
     
  • CMC Crypto 200

    435.20
    -23.94 (-5.21%)
     
  • FTSE 100

    6,953.42
    -31.17 (-0.45%)
     
  • Nikkei 225

    26,173.98
    -397.89 (-1.50%)
     

Don't be duped by doomsayers, JPMorgan says — the S&P will rebound to 4,900. Here are 3 stocks it's using to bet on a bounce

·4 min read
Don't be duped by doomsayers, JPMorgan says — the S&P will rebound to 4,900. Here are 3 stocks it's using to bet on a bounce
Don't be duped by doomsayers, JPMorgan says — the S&P will rebound to 4,900. Here are 3 stocks it's using to bet on a bounce

Looking at the S&P 500 right now, you might be convinced the stock market is destined for doom in 2022.

The benchmark index rose nearly 27% last year. This year, it’s already down 22%. Plenty of stocks are deep into correction territory.

Yet JPMorgan’s global head of equity macro research, Dubravko Lakos, sees a major rebound on the horizon.

“People are basically positioned for a recession. Our base case is that this is not going to be a recession in the next 12 months,” Lakos told CNBC earlier this month. “And we think from that angle the portfolios are wrong footed.”

Lakos reiterated a year-end price target of 4,900 for the S&P 500. Since the index sits at 3,736 today, his target implies a potential upside of around 31%.

If you’re aligned with Lakos and are looking ahead to a potential reversal, here’s three stocks JPMorgan finds particularly attractive right now.

Don't miss

  • Bill Gates says crypto and NFTs are a fool's game — here's the surprising thing he buys instead

  • Mitt Romney says a billionaire tax will trigger demand for these two assets — get in now before the super-rich swarm

  • Eager to escape the dismal stock market? Unfortunately, “cash is not a safe investment,” says Ray Dalio, founder of the world’s largest hedge fund. “It’s not a safe place because it will be taxed by inflation.” With the consumer price index hitting a 40-year high of 8.6% in May, you’ll need to get creative to find strong returns.

Smartsheet (SMAR)

This work-management platform helps companies implement, organize and automate their processes. Smartsheet says its application is used by more than 80% of Fortune 500 companies.

And business is growing. In the fiscal quarter ended April 30, revenue surged 44% year over year to $168.3 million, driven by a 44% increase in subscription revenue.

Notably, Smartsheet’s dollar-based net retention rate was a solid 133%.

But the stock is far from being a hot commodity. Year to date, shares are down a painful 61%. That could give contrarian investors something to think about.

Last week, JPMorgan analyst Pinjalim Bora reiterated an “overweight” rating on Smartsheet. While Bora also lowered his price target from $80 to $58, the new target is still 96% above where the stock sits today.

Microsoft (MSFT)

Tech stocks are getting dumped in this market downturn. Even mega-cap behemoths like Microsoft aren’t immune to the bearish sentiment.

The stock has tumbled 26% in 2022.

But business remains on the right track. In the March quarter, Microsoft’s revenue grew 18% year over year to $49.4 billion. Adjusted earnings came in at $2.22 per share, up 9% from the year-ago period.

The tech gorilla is also returning a massive amount of cash to investors. For the quarter, Microsoft’s dividends and share buybacks totaled $12.4 billion, representing a 25% increase year over year.

JPMorgan analyst Mark Murphy recently raised his price target on Microsoft to $320 while maintaining a “buy” rating. That implies a potential upside of 30%.

Eli Lilly (LLY)

This American pharmaceutical giant commands more than $270 billion in market cap, with products marketed in 120 countries around the world.

Unlike the other two names on this list, Eli Lilly is not a beaten-down stock.

In Q1, Eli Lilly delivered 15% revenue growth, driven by a 20% growth in volume. The company paid nearly $900 million in dividends and spent $1.5 billion on buybacks during the quarter.

Shares are actually up 7% so far in 2022, and JPMorgan expects the trend to continue.

On June 1, analyst Chris Schott reiterated an “overweight” rating on Eli Lilly while raising his price target from $340 to $355.

Considering that shares trade at around $291 apiece right now, the new price target implies a potential upside of 22%.

What to read next

This article provides information only and should not be construed as advice. It is provided without warranty of any kind.